FTC issues more warnings to drug companies for ‘junk’ patent listings; Eli Lilly raises earnings guidance as Zepbound sales beat expectations
Taking stock of the drug industry, from the lab to the medicine chest April 30, 2024 Check out STAT+ Sponsored By By Ed Silverman Pharmalo...Read More